For centuries, chamomile has served as a traditional remedy for insomnia, upset stomach, and inflammation. In recent years, scientific inquiry has expanded into its possible cancer-fighting properties. Laboratory investigations have demonstrated that certain phytochemicals in chamomile—particularly apigenin and luteolin—may inhibit the multiplication of cancer cells in cell cultures. Apigenin and luteolin appear to disrupt critical cellular mechanisms that enable cancer cells to metastasize. For https://asresalamat.ir/7-properties-of-chamomile-tea-what-is-chamomile-tea-good-for/, Learn Alot more, example suggests that apigenin can induce apoptosis—programmed cell death—in malignant cells while preserving healthy cells. The documented outcomes have been noted in tissue samples of cancers of the breast, prostate, skin, and GI tract. However, these findings originated from artificial experimental environments and may not directly reflect equivalent effects in the human body. Medical trials involving chamomile derivatives in oncology populations remain extremely scarce. Using chamomile tea or chamomile supplements is considered low-risk for most individuals, they cannot substitute for medically approved interventions. Scientists continue to explore whether chamomile compounds could complement existing treatments or mitigate treatment-related side effects such as inflammation and cellular damage from free radicals. Higher-quality human clinical trials are essential to establish whether chamomile can offer tangible benefits in lowering tumor incidence or therapeutic intervention. At present, chamomile remains a promising subject of research—but not a validated remedy.